Literature DB >> 32816064

Intracellular RET signaling pathways activated by GDNF.

Kumi Kawai1, Masahide Takahashi2,3.   

Abstract

Activation of REarranged during Transfection (RET) proto-oncogene is responsible for various human cancers such as papillary and medullary thyroid carcinomas and non-small cell lung carcinomas. RET activation in these tumors is caused by point mutations or gene rearrangements, resulting in constitutive activation of RET tyrosine kinase. Physiologically, RET is activated by glial cell line-derived neurotrophic factor (GDNF) ligands that bind to coreceptor GDNF family receptor alphas (GFRαs), leading to RET dimerization. GDNF-GFRα1-RET signaling plays crucial roles in the development of the enteric nervous system, kidney and lower urinary tract as well as in spermatogenesis. Intracellular tyrosine phosphorylation in RET and recruitment of adaptor proteins to phosphotyrosines are essential for various biological functions. Significance of intracellular RET signaling pathways activated by GDNF is discussed and summarized in this review.

Entities:  

Keywords:  GDNF; GDNF family receptor α; Intracellular signaling; Oncogene; RET; Tyrosine phosphorylation

Mesh:

Substances:

Year:  2020        PMID: 32816064     DOI: 10.1007/s00441-020-03262-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  13 in total

1.  Neurotrophin Regulation and Signaling in Airway Smooth Muscle.

Authors:  Benjamin B Roos; Jacob J Teske; Sangeeta Bhallamudi; Christina M Pabelick; Venkatachalem Sathish; Y S Prakash
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.

Authors:  Lin Liu; Liqiong Zhao; Jie Zhang; Guoxiang Song; Carol L Shields; Ruihua Wei
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

3.  Genetic interplay between transcription factor Pou4f1/Brn3a and neurotrophin receptor Ret in retinal ganglion cell type specification.

Authors:  Vladimir Vladimirovich Muzyka; Tudor Constantin Badea
Journal:  Neural Dev       Date:  2021-09-21       Impact factor: 3.842

Review 4.  Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy.

Authors:  Karen M Delgado-Minjares; Daniel Martinez-Fong; Irma A Martínez-Dávila; Cecilia Bañuelos; M E Gutierrez-Castillo; Víctor Manuel Blanco-Alvarez; Maria-Del-Carmen Cardenas-Aguayo; José Luna-Muñoz; Mar Pacheco-Herrero; Luis O Soto-Rojas
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

Review 5.  Update on Targeted Therapy in Medullary Thyroid Cancer.

Authors:  Christian Okafor; Julie Hogan; Margarita Raygada; Barbara J Thomas; Srivandana Akshintala; John W Glod; Jaydira Del Rivero
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-19       Impact factor: 5.555

Review 6.  RET receptor signaling: Function in development, metabolic disease, and cancer.

Authors:  Masahide Takahashi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2022       Impact factor: 3.493

7.  Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the GDNF-LIF Interaction.

Authors:  Ning Ke; Lin Chen; Qing Liu; Haibo Xiong; Xinke Chen; Xiyuan Zhou
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

8.  Reawakening GDNF's regenerative past in mice and humans.

Authors:  Andres Samos; Vanessa McGaughey; Sandra Rieger; Thomas S Lisse
Journal:  Regen Ther       Date:  2022-04-19       Impact factor: 3.651

Review 9.  Novel insights on GM1 and Parkinson's disease: A critical review.

Authors:  Maria Fazzari; Erika Di Biase; Giulia Lunghi; Laura Mauri; Elena Chiricozzi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2022-01-22       Impact factor: 2.916

10.  Glial-derived neurotrophic factor in human airway smooth muscle.

Authors:  Sangeeta Bhallamudi; Benjamin B Roos; Jacob J Teske; Sarah A Wicher; Andrea McConico; Christina M Pabelick; Venkatachalem Sathish; Y S Prakash
Journal:  J Cell Physiol       Date:  2021-06-25       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.